Format

Send to

Choose Destination

See 1 citation found by title matching your search:

Child Adolesc Psychiatry Ment Health. 2008 Sep 15;2(1):24. doi: 10.1186/1753-2000-2-24.

Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring.

Author information

1
Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. jzito@rx.umaryland.edu

Abstract

The review presents pediatric adverse drug events from a historical perspective and focuses on selected safety issues associated with off-label use of medications for the psychiatric treatment of youth. Clinical monitoring procedures for major psychotropic drug classes are reviewed. Prior studies suggest that systematic treatment monitoring is warranted so as to both minimize risk of unexpected adverse events and exposures to ineffective treatments. Clinical trials to establish the efficacy and safety of drugs currently being used off-label in the pediatric population are needed. In the meantime, clinicians should consider the existing evidence-base for these drugs and institute close clinical monitoring.

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center